Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid before simultaneous bilateral total knee arthroplasty
ChiCTR-IPR-15006572Phase 4Recruiting
- Sponsor
- Xijing Hospital
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of tranexamic acid in knee osteoarthritis (OA) (2 arms), sponsored by Xijing Hospital. Primary endpoints: Proportion of patients transfused with allogeneic blood and Amount of allogeneic blood transfused. Started Apr 2014; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR-IPR-15006572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006572.